Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2010

Open Access 01-12-2010 | Research

Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study

Authors: Lecy Kawamura, Filomena M Carvalho, Bernardo GL Alves, Carlos E Bacchi, Joao Carlos Sampaio Goes, Marcelo Alvarenga Calil, Edmund C Baracat, Jesus P Carvalho

Published in: World Journal of Surgical Oncology | Issue 1/2010

Login to get access

Abstract

Background

Lymph node metastasis in endometrial cancer significantly decreases survival rate. Few data on the influence of intratumoral lymphatic microvessel density (LMVD) on survival in endometrial cancer are available. Our aim was to assess the intratumoral LMVD of endometrial carcinomas and to investigate its association with classical pathological factors, lymph node metastasis and survival.

Methods

Fifty-seven patients with endometrial carcinoma diagnosed between 2000 and 2008 underwent complete surgical staging and evaluation of intratumoral LMVD and other histologic variables. Lymphatic microvessels were identified by immunohistochemical staining using monoclonal antibody against human podoplanin (clone D2-40) and evaluated by counting the number of immunostained lymphatic vessels in 10 hot spot areas at 400× magnification. The LMVD was expressed by the mean number of vessels in these 10 hot spot microscopic fields. We next investigated the association of LMVD with the clinicopathologic findings and prognosis.

Results

The mean number of lymphatic vessels counted in all cases ranged between 0 and 4.7. The median value of mean LMVD was 0.5, and defined the cut-off for low and high LMVD. We identified low intratumoral LMVD in 27 (47.4%) patients and high LMVD in 30 (52.6%) patients. High intratumoral LMVD was associated with lesser miometrial and adnaexal infiltration, lesser cervical and peritoneal involvement, and fewer fatal cases. Although there was lower lymph node involvement among cases with high LMVD, the difference did not reach significance. No association was seen between LMVD and FIGO staging, histological type, or vascular invasion. On the other hand, low intratumoral LMVD was associated with poor outcome. Seventy-five percent of deaths occurred in patients with low intratumoral LMVD.

Conclusion

Our results show association of high intratumoral LMVD with features related to more localized disease and better outcome. We discuss the role of lymphangiogenesis as an early event in the endometrial carcinogenesis.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC: Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 2002, 84: 437-442.CrossRefPubMed Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC: Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 2002, 84: 437-442.CrossRefPubMed
4.
go back to reference Hoekstra AV, Kim RJ, Small W, Rademaker AW, Helenowski IB, Singh DK, Schink JC, Lurain JR: FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol. 2009, 114: 273-278.CrossRefPubMed Hoekstra AV, Kim RJ, Small W, Rademaker AW, Helenowski IB, Singh DK, Schink JC, Lurain JR: FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol. 2009, 114: 273-278.CrossRefPubMed
5.
go back to reference Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB: First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer. 2006, 95: 1611-1625.PubMedCentralCrossRefPubMed Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB: First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer. 2006, 95: 1611-1625.PubMedCentralCrossRefPubMed
6.
go back to reference Cao Y: Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer. 2005, 5: 735-743.CrossRefPubMed Cao Y: Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer. 2005, 5: 735-743.CrossRefPubMed
7.
go back to reference Liersch R, Biermann C, Mesters RM, Berdel WE: Lymphangiogenesis in cancer: current perspectives. Recent Results Cancer Res. 2010, 180: 115-135.CrossRefPubMed Liersch R, Biermann C, Mesters RM, Berdel WE: Lymphangiogenesis in cancer: current perspectives. Recent Results Cancer Res. 2010, 180: 115-135.CrossRefPubMed
8.
go back to reference Zhang SQ, Yu H, Zhang LL: Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study. BMC Cancer. 2009, 9: 64-PubMedCentralCrossRefPubMed Zhang SQ, Yu H, Zhang LL: Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study. BMC Cancer. 2009, 9: 64-PubMedCentralCrossRefPubMed
9.
go back to reference Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G: Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2005, 11: 8364-8371.CrossRefPubMed Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G: Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2005, 11: 8364-8371.CrossRefPubMed
10.
go back to reference Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G: Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001, 95: 29-33.CrossRefPubMed Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G: Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001, 95: 29-33.CrossRefPubMed
11.
go back to reference Vandenput I, Vanhove T, Calster BV, Gorp TV, Moerman P, Verbist G, Vergote I, Amant F: The use of lymph vessel markers to predict endometrial cancer outcome. Int J Gynecol Cancer. 2010, 20: 363-367.CrossRefPubMed Vandenput I, Vanhove T, Calster BV, Gorp TV, Moerman P, Verbist G, Vergote I, Amant F: The use of lymph vessel markers to predict endometrial cancer outcome. Int J Gynecol Cancer. 2010, 20: 363-367.CrossRefPubMed
12.
go back to reference Stefansson IM, Salvesen HB, Akslen LA: Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006, 66: 3303-3309.CrossRefPubMed Stefansson IM, Salvesen HB, Akslen LA: Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006, 66: 3303-3309.CrossRefPubMed
13.
go back to reference Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009, 105: 103-104.CrossRefPubMed Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009, 105: 103-104.CrossRefPubMed
14.
go back to reference Tavassoli FA, Deville A: Pathology & Genetics Tumours of Breast and Female Genital Organs. 2003, Lion: International Agency for Research on Cancer - IARC Press Tavassoli FA, Deville A: Pathology & Genetics Tumours of Breast and Female Genital Organs. 2003, Lion: International Agency for Research on Cancer - IARC Press
15.
go back to reference Alkushi A, Abdul-Rahman ZH, Lim P, Schulzer M, Coldman A, Kalloger SE, Miller D, Gilks CB: Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol. 2005, 29: 295-304.CrossRefPubMed Alkushi A, Abdul-Rahman ZH, Lim P, Schulzer M, Coldman A, Kalloger SE, Miller D, Gilks CB: Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol. 2005, 29: 295-304.CrossRefPubMed
16.
go back to reference Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129: 716-719.CrossRefPubMed Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129: 716-719.CrossRefPubMed
17.
go back to reference Epi Info. 2008, Atlanta, GA: Centers for Disease Control and Prevention (CDC), 3.5.1 Epi Info. 2008, Atlanta, GA: Centers for Disease Control and Prevention (CDC), 3.5.1
18.
go back to reference Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature. 2005, 438: 946-953.CrossRefPubMed Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature. 2005, 438: 946-953.CrossRefPubMed
19.
go back to reference He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 2005, 65: 4739-4746.CrossRefPubMed He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 2005, 65: 4739-4746.CrossRefPubMed
20.
go back to reference Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002, 2: 573-583.CrossRefPubMed Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002, 2: 573-583.CrossRefPubMed
21.
22.
go back to reference Gao Y, Liu Z, Gao F, Meng XY: High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study. BMC Cancer. 2010, 10: 131-PubMedCentralCrossRefPubMed Gao Y, Liu Z, Gao F, Meng XY: High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study. BMC Cancer. 2010, 10: 131-PubMedCentralCrossRefPubMed
23.
go back to reference Donoghue JF, Lederman FL, Susil BJ, Rogers PA: Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod. 2007, 22: 1705-1713.CrossRefPubMed Donoghue JF, Lederman FL, Susil BJ, Rogers PA: Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod. 2007, 22: 1705-1713.CrossRefPubMed
24.
go back to reference Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002, 296: 1883-1886.CrossRefPubMed Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002, 296: 1883-1886.CrossRefPubMed
25.
go back to reference Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG: Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002, 16: 1985-1987.PubMed Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG: Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002, 16: 1985-1987.PubMed
Metadata
Title
Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study
Authors
Lecy Kawamura
Filomena M Carvalho
Bernardo GL Alves
Carlos E Bacchi
Joao Carlos Sampaio Goes
Marcelo Alvarenga Calil
Edmund C Baracat
Jesus P Carvalho
Publication date
01-12-2010
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2010
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-8-89

Other articles of this Issue 1/2010

World Journal of Surgical Oncology 1/2010 Go to the issue